Health Innovation South West partners with Helfie AI

Melbourne, Australia - Health Innovation South West has teamed up with UK-based Helfie AI to investigate how digital methods can aid in the early detection of hypertension and cardiovascular disease. This collaboration aims to test and evaluate smartphone-based screening technology to encourage people to take part in prevention efforts, especially those who may have difficulties accessing conventional healthcare services.

Hypertension ranks among the major risk factors for cardiovascular disease, yet many individuals remain undiagnosed until they face serious health issues. By merging Helfie's technology with Health Innovation South West's expertise in implementation and evaluation, this partnership seeks to explore the potential integration of smartphone-enabled screening into healthcare systems, with a focus on enhancing access for underserved and hard-to-reach populations.

The insights gleaned from this program will bolster the evidence base for innovative prevention strategies and population health initiatives. Rania Awad, Chief Strategy Officer at Helfie AI, emphasized that prevention is only effective when it reaches people in their environments. Their mission revolves around early detection, proactive prevention, and optimized wellbeing for all eight billion-plus individuals, including those who struggle to reach clinics.

Christelle Kelley, Population Health Lead at Helfie AI, highlighted that population health entails understanding community needs and tailoring prevention measures accordingly. She expressed enthusiasm in exploring how digital innovation can extend beyond conventional healthcare settings and promote place-based care. The partnership aims to not only identify more individuals at risk of hypertension but also translate this opportunity into significant, equitable improvements in cardiovascular health.

More information is available at www.helfie.ai. Helfie AI has contributed financially to this project, covering aspects of evaluating the impact of incorporating the platform into cardiovascular disease prevention pathways. The outcomes and findings from this partnership should not be taken as an endorsement, recommendation, or procurement advice from Health Innovation South West concerning any specific product, technology, or manufacturer.